As the pharmaceutical industry continues to take on an expanding role in the development of breakthrough medication, pharmacy solutions organizations will be just as essential in ensuring their delivery. Published in partnership with myMatrixx parent company, Cigna, this paper discusses the critical work these entities, which include workers’ compensation PBMs, need to do to deliver therapies to the correct patients, at the right time, in the appropriate setting and at affordable costs. Specifically, myMatrixx Chief Clinical Officer, Phil Walls, covers this topic from a workers’ compensation perspective, sharing how much an aging population with a growing list of comorbidities is affecting the cost and safe delivery of drug therapy for injured workers while also emphasizing the ongoing role of generic substitution.